Join our growing community to challenge mainstream media bias and fix the news
Pharma company Novavax commences late stage vaccine trial in UK

Pharma company Novavax commences late stage vaccine trial in UK

US based Novavax has commenced late stage trial of its potential COVID-19 vaccine in UK because the Covid-19 is spreading drastically in UK and is likely to produce quick results. Novavax aims to test efficiency of its vaccine in a trial involving 10,000 people between age of 18 & 84. At least 25% of subjects will be over age of 65, and 400 participants will also receive a licensed flu vaccine.

Milan
Milan
HiDragon456
HiDragon456 4 weeks

Hopefully a safe vaccine will be finished as soon as possible so we can start distributing it.

Top in Business